CHRISTOPHER ROBINSON: Open Payments
NPI 1952558892 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$729 in 15 payments from 11 companies in 2025. Trend: 2023 $797 · 2024 $446 · 2025 $729
Travel & lodging: $419Food & beverage: $310
| Company | Payments | Amount |
|---|---|---|
| Smith+Nephew, Inc. | 1 | $419 |
| Ferring Pharmaceuticals Inc. | 2 | $50 |
| Sumitomo Pharma America, Inc. | 2 | $49 |
| Janssen Biotech, Inc. | 2 | $44 |
| Antares Pharma, Inc. | 2 | $35 |
| Boston Scientific Corporation | 1 | $28 |
| Verity Pharmaceuticals Inc. | 1 | $25 |
| Sagent Pharmaceuticals | 1 | $22 |
| Teleflex LLC | 1 | $22 |
| Endo USA, Inc. | 1 | $18 |
Products named: EVOS, ADSTILADRIN, GEMTESA, ERLEADA, XYOSTED, Advantage System, Trelstar, Glydo.
Industry payments across SC — which companies pay providers there.
